|
Svante, a Canadian carbon capture technology provider, landed $318 million in Series E funding led by Chevron. New investors including 3M Ventures, Full Circle Capital, GE Vernova, Japan Energy Fund, TechEnergy Ventures and United Airlines Ventures also joined in the round, along with existing backers Temasek and OGCI Climate Investments.
Mews, a Prague-based property management system for hotels, completed a $185 million Series C round. Kinnevik and the Growth Equity business within Goldman Sachs Asset Management led the investment, which included additional participation from Revaia, Derive Ventures, Orbit Capital, Battery Ventures, Notion Capital, Salesforce Ventures, Thayer Ventures and HenQ. Akhil Chainwala from Kinnevik and Kirk Lepke from Goldman Sachs joined the company’s board.
MasterControl Inc., a Salt Lake City-based software vendor for life sciences and other regulated industries, secured $150 million in Series A financing led by Sixth Street Growth.
Nerdio, a Chicago-based Microsoft Azure management platform, closed a $117 million Series B round from Updata Partners.
Aztec Network, an encrypted blockchain startup, scored $100 million in Series B funding led by Andreessen Horowitz’s a16z crypto.
Synchron, a Brooklyn, N.Y.-based developer of an endovascular brain computer interface, raised $75 million in Series C funding led by ARCH Venture Partners. Additional new investors including Bezos Expeditions, Reliance Digital Health, Greenoaks, Alumni Ventures and Moore Strategic Ventures also participated in the round, alongside previous backers Khosla Ventures, NeuroTechnology Investors, Forepont Capital Partners, ID8 Investments and Shanda Group. Ari Nowacek from ARCH Venture Partners will join the Synchron board.
Enlaza Therapeutics, a La Jolla, Calif.-based developer of covalent protein therapeutics for the treatment of cancer and other serious diseases, launched with $61 million in seed funding. Lead investor Avalon Ventures was joined by Lightspeed Venture Partners, Frazier Healthcare Partners and Samsara BioCapital in the round.
BillionToOne Inc., a Menlo Park, Calif.-based molecular diagnostics startup, added $48.5 million in equity funding, along with up to $35 million in an upsized term loan facility. Equity investors included Libertus Capital, Hummingbird Ventures, Baillie Gifford, Adams Street Partners, Neotribe Ventures, Fifty Years, Norwest Venture Partners and Time BioVentures. Debt was provided by Bridge Bank.
DataVisor Inc., a Mountain View, Calif.-based provider of online fraud detection and risk management software for financial services and digital commerce, picked up a $40 million strategic growth investment. Led by Brighton Park Capital, the round included additional support from NewView Capital, GSR Ventures and others.
Gilgamesh Pharmaceuticals, a New York-based startup developing treatments for depression and other mental health disorders, raised $39 million in Series B financing. Led by Prime Movers Lab, the round included support from Alumni Ventures, Palo Santo, Negev Capital, Route 66 Ventures, JLS Fund, Satori Capital and Gron Ventures.
SafeAI, a Santa Clara, Calif.-based provider of autonomous technology for heavy equipment, snagged $38 million in Series B financing from investors including Builders VC, McKinley Management, George Kaiser Family Foundation, Energy Innovation Capital and Moog Inc.
Element Energy, a Menlo Park, Calif.-based battery management technology startup, collected $28 million in Series B funding from investors including Cohort Ventures, LG Technology Ventures, Edison International, Prelude Ventures and Radar Partners. Matt Murphy, president and chief executive of Marvell Technology, will join the board.
|